Molecular genetic analysis in the pathologic evaluation of solid tumors: theory and practice.
作者信息
Visscher D W, Sarkar F H, Crissman J D
机构信息
Department of Pathology, Harper Hospital, Detroit, Michigan 48201, USA.
出版信息
J Clin Lab Anal. 1997;11(1):10-6. doi: 10.1002/(SICI)1098-2825(1997)11:1<10::AID-JCLA3>3.0.CO;2-O.
Abstract
摘要
相似文献
1
Molecular genetic analysis in the pathologic evaluation of solid tumors: theory and practice.
J Clin Lab Anal. 1997;11(1):10-6. doi: 10.1002/(SICI)1098-2825(1997)11:1<10::AID-JCLA3>3.0.CO;2-O.
2
p53 mutations in BRCA1-associated familial breast cancer.
Lancet. 1998 Aug 22;352(9128):622. doi: 10.1016/S0140-6736(05)79576-3.
3
Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations.
J Natl Cancer Inst. 1999 Mar 3;91(5):469-73. doi: 10.1093/jnci/91.5.469.
4
Hereditary breast cancer.
Curr Probl Surg. 2001 Jun;38(6):387-480.
5
Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.
Ann Oncol. 2000 Mar;11(3):307-13. doi: 10.1023/a:1008340723974.
6
Survival and tumor characteristics of German hereditary breast cancer patients.
Breast Cancer Res Treat. 2000 Jan;59(2):185-92. doi: 10.1023/a:1006350518190.
7
Introduction: BRCA1 and BRCA2 in mammary gland development and tumorigenesis.
J Mammary Gland Biol Neoplasia. 1998 Oct;3(4):363-4. doi: 10.1023/a:1018727813904.
8
Prognosis of BRCA1 hereditary breast cancer.
Lancet. 1998 Jan 31;351(9099):304-5. doi: 10.1016/S0140-6736(98)22005-8.
9
BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women.
Ann N Y Acad Sci. 1997 Dec 29;833:198-203. doi: 10.1111/j.1749-6632.1997.tb48610.x.
10
Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.
Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):539-46. doi: 10.1016/s0360-3016(00)01481-4.
本文引用的文献
1
In primary human breast carcinomas mutations in exons 5 and 6 of the p53 gene are associated with a high S-phase index.
Int J Cancer. 1993 Jun 19;54(4):531-5. doi: 10.1002/ijc.2910540402.
2
Genetic counseling for families with inherited susceptibility to breast and ovarian cancer.
JAMA. 1993 Apr 21;269(15):1970-4.
3
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.
Cell. 1993 Dec 3;75(5):1027-38. doi: 10.1016/0092-8674(93)90546-3.
4
p53 immunohistochemistry: a word of caution.
Hum Pathol. 1994 May;25(5):435-7. doi: 10.1016/0046-8177(94)90113-9.
5
On the expression of the p53 protein in human cancer.
Mol Biol Rep. 1994 Jan;19(1):23-9. doi: 10.1007/BF00987319.
6
High frequency of allelic imbalance at the BRCA1 region on chromosome 17q in both familial and sporadic ductal breast carcinomas.
J Natl Cancer Inst. 1994 May 18;86(10):792-4. doi: 10.1093/jnci/86.10.792.
7
Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.
Cancer Res. 1993 Jul 15;53(14):3382-5.
8
Rapid and specific diagnosis of t(11;22) translocation in paediatric Ewing's sarcoma and primitive neuroectodermal tumours using RNA-PCR.
J Clin Pathol. 1994 Jun;47(6):562-4. doi: 10.1136/jcp.47.6.562.
9
Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations.
Diagn Mol Pathol. 1994 Jun;3(2):83-92. doi: 10.1097/00019606-199406000-00004.
10
Breast cancer gene. Many mutations may make test difficult.
Science. 1994 Dec 2;266(5190):1470. doi: 10.1126/science.7985008.
Zotero 插件